Showing results (61-70 of 4,345) with videos related to
Sort By:
Pageof 435
American Journal of Clinical Oncology|April 1, 1983
A phase II study of alanosine in advanced large bowel carcinomaJ Rubin, V Hineman, C G Moertel, et al.Cancer|November 1, 1978
Chemotherapy studies in primary liver cancer: a prospective randomized clinical trialG Falkson, C G Moertel, P Lavin, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patientsG Powis, P Reece, D L Ahmann, et al.American Journal of Epidemiology|July 20, 2000
External radiation exposure and mortality in a cohort of uranium processing workersE Dupree-Ellis, J Watkins, J N Ingle, et al.British Journal of Cancer|June 10, 2004
Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literatureC Adem, C Reynolds, J N Ingle, et al.Cancer|December 15, 1988
A phase I clinical trial of recombinant human tumor necrosis factorE T Creagan, J S Kovach, C G Moertel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumorP F Engstrom, P T Lavin, C G Moertel, et al.Cancer Treatment Reports|February 1, 1980
Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinomaM J O'Connell, C G Moertel, J Rubin, et al.Cancer Chemotherapy Reports|March 1, 1975
Adriamycin (NSC-123127) therapy for advanced gastrointestinal cancerS Frytak, C G Moertel, A J Schutt, et al.Cancer Research|September 1, 1979
A comparative clinical and immunological assessment of methanol extraction residue of Bacillus Calmette-Guérin versus placebo in patients with advanced cancerM J O'Connell, C G Moertel, R E Ritts, et al.Pageof 435